Onconova Therapeutics

Home » Onconova Therapeutics

Follow-on

Onconova Therapeutics

Biopharmaceutical

Onconova Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule product candidates primarily to treat cancer.

Symbol

ONTX

Last Closing Price
$2.58

Shares
2,000,000

Anticipated Date
September 18, 2019

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Onconova Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253